{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:46:33Z","timestamp":1786967193817,"version":"build-2736575974"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,5,27]],"date-time":"2003-05-27T00:00:00Z","timestamp":1053993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psycho-Oncology"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Background<\/jats:italic>. Most quality\u2010of\u2010life (QoL) studies in autologous Peripheral Blood Stem Cell Transplantation (PBSCT) are descriptive and concentrate on symptom severity and functional deficits. The aim of this study is to compare individual QoL (iQoL) with health\u2010related QoL (hrQoL) and functional status of patients before high\u2010dosed therapy\/PBSCT.<\/jats:p><jats:p><jats:italic>Patients and methods<\/jats:italic>. Multiple Myeloma, non\u2010Hodgkin's Lymphoma and other tumor patients were asked to complete the following measures before high\u2010dosed therapy\/PBSCT: the European Organization for Research and Treatment of Cancer (EORTC) Quality\u2010of\u2010life Questionnaire Core 30 (QLQ\u2013C30), and the Schedule for the Evaluation of Individual QoL\u2014Direct Weighting (SEIQoL\u2013DW), a patient\u2010generated instrument which allows the patients to nominate the five most important domains (cues) for their present QoL. The SEIQoL\u2010DW assessment generates: (1) a global QoL score (SEIQoL\u2010INDEX), calculated as \u03a3(levels\u00d7weights); (2) the current overall QoL, rated on a visual analogue scale (VAS). Additional measures included demographic data, clinical disease status of remission and Karnofsky's index.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>. Seventy\u2010nine patients completed both types of questionnaires. The QoL domains nominated by the patients were assigned to groups (aggregated cues), the most frequent of which were family (89%), hobbies\/pastimes (74%), health (physical, including mobility) (70%), profession\/occupation (51%), social life\/friends (47%) and marriage\/partnership (33%). There was no correlation between the SEIQoL\u2010DW total scores and the EORTC QLQ\u2010C30 scale or the Karnofsky index.<\/jats:p><jats:p><jats:italic>Conclusion<\/jats:italic>. Individual QoL as assessed by the SEIQoL\u2013DW is unrelated to standard health\u2010status measures such as the EORTC QLQ\u2010C30 or the Karnofsky index. Patient\u2010perceived iQoL in PBSCT seems to depend largely on areas others than health and physical functioning, with the family playing a prominent role. Copyright \u00a9 2003 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/pon.730","type":"journal-article","created":{"date-parts":[[2004,2,9]],"date-time":"2004-02-09T18:32:35Z","timestamp":1076351555000},"page":"116-124","source":"Crossref","is-referenced-by-count":42,"title":["Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation"],"prefix":"10.1002","volume":"13","author":[{"given":"E.","family":"Frick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D.","family":"Borasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zehentner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bumeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,5,27]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"185","volume-title":"The EORTC Core Quality of Life Questionnaire: Interim Results of An International Field Study","author":"Aaronson N","year":"1991"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(96)00339-5"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702022"},{"key":"e_1_2_1_6_1","first-page":"101","article-title":"Comparison of two modes of administration of a personalized quality of life scale in a longitudinal study of total hip arthroplasty","volume":"67","author":"Bayle B","year":"2000","journal-title":"Joint Bone Spine"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1300\/J077V16N01_02"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.2.320"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00434897"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jme.10.3.124"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.1999.01079.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016704906100"},{"key":"e_1_2_1_13_1","first-page":"1025","article-title":"Quality of life in oncology practice: prognostic value of EORTC QLQ\u2010C30 scores in patients with advanced malignancy","volume":"33","author":"Coates A","year":"1997","journal-title":"Eur J Cancer Clin Oncol"},{"key":"e_1_2_1_14_1","first-page":"821","article-title":"Quality of life evaluation in oncological clinical trials\u2014the EORTC model","volume":"36","author":"de Haes J","year":"2000","journal-title":"Eur J Cancer Clin Oncol"},{"key":"e_1_2_1_15_1","volume-title":"Wissenschaftliche Tabellen","author":"Diem K","year":"1969"},{"key":"e_1_2_1_16_1","unstructured":"FrickE BumederI.Psychotherapeutic value of determining individual quality of life after Autologous Peripheral Stem Cell Transplant in preparation."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/002188637601200201"},{"key":"e_1_2_1_18_1","first-page":"141","article-title":"Das Zufriedenheitsparadox in der Lebensqualit\u00e4tsforschung. Wovon h\u00e4ngt unser Wohlbefinden ab?","volume":"52","author":"Herschbach P","year":"2002","journal-title":"PPmP"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7048.29"},{"key":"e_1_2_1_20_1","first-page":"1921","article-title":"How can we measure individual quality of life?","volume":"124","author":"Joyce CRB","year":"1994","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_1_21_1","first-page":"199","volume-title":"The Clinical Evaluation of Chemotherapeutic Agents in Cancer","author":"Karnofsky DA","year":"1949"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-6054(96)80223-6"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012219504134"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2000.01486.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700022388"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1348\/135910799168696"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(01)00612-8"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90673-Q"},{"key":"e_1_2_1_29_1","first-page":"159","article-title":"Quality of life: assessing the individual","volume":"5","author":"O'Boyle CA","year":"1994","journal-title":"Adv Med Sociol"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016742628834"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00447-0"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.4"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/heart.84.4.390"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.11.3603"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00050-7"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.352889.x"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1611(199901\/02)8:1<64::AID-PON337>3.0.CO;2-R"}],"container-title":["Psycho-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpon.730","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pon.730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T19:07:26Z","timestamp":1700248046000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pon.730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,27]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1002\/pon.730"],"URL":"https:\/\/doi.org\/10.1002\/pon.730","archive":["Portico"],"relation":{},"ISSN":["1057-9249","1099-1611"],"issn-type":[{"value":"1057-9249","type":"print"},{"value":"1099-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,27]]}}}